FDA Issues Warning Letter to Battelle Memorial Institute, a Manufacturer of an Authorized Decontamination System Used on Respirators | FDA

FDA Issues Warning Letter to Battelle Memorial Institute, a Manufacturer of an Authorized Decontamination System Used on Respirators | FDA

FDA Office of Minority Health and Health Equity

Coronavirus Disease 2019 (COVID-19) Updates Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last email update include: October 13, 2020: Daily roundup on new guidance regarding molecular influenza and RSV tests October 7, 2020: FDA Issues Warning Letter to Battelle Memorial Institute, a Manufacturer of an Authorized Decontamination System Used on Respirators Bookmark www.fda.gov/coronavirus for the latest. Antimicrobial resistance update Potential approach for ranking of antimicrobial drugs according to their importance in human medicine FDA released a concept paper, Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial New Animal Drugs, for public comment and announced a virtual public meeting on November 16, 2020. Register by November 12, 2020. Also see: Antimicrobial Resistance Information from FDA (October 9, 2020) Find additional coronavirus disease 2019 (COVID-19) updates on our website and in the Medical Countermeasures Initiative newsletter.